Home > Income Statement > MARKSANS PHARMA

MARKSANS PHARMA
Revenue

    Back to Income Statement
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹2,177 Cr₹1,852 Cr₹1,491 Cr₹1,376 Cr₹1,134 Cr

What is the latest Revenue of MARKSANS PHARMA ?

The latest Revenue ratio of MARKSANS PHARMA is ₹2,177 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹2,177 Cr
Mar2023₹1,852 Cr
Mar2022₹1,491 Cr
Mar2021₹1,376 Cr
Mar2020₹1,134 Cr

How is Revenue of MARKSANS PHARMA Trending?

Years Revenue % Change
Mar2024 ₹2,177 Cr
17.56
Mar2023 ₹1,852 Cr
24.23
Mar2022 ₹1,491 Cr
8.33
Mar2021 ₹1,376 Cr
21.33
Mar2020 ₹1,134 Cr -

Compare Revenue of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹10,840.5 Cr 1.2% -16.2% 61.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,472.0 Cr 0.2% -5.8% 23.9% Stock Analytics
DIVIS LABORATORIES ₹156,342.0 Cr 4.8% 0% 53.8% Stock Analytics
CIPLA ₹114,754.0 Cr -0.2% -4.7% 3.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,465.0 Cr 1.9% -10.9% 0.6% Stock Analytics
ZYDUS LIFESCIENCES ₹96,875.2 Cr 3.2% 0.1% 28.1% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

1.2%

-16.2%

61.6%

SENSEX

1.7%

-2.6%

7.6%


You may also like the below Video Courses